Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Digestive involvement of scleroderma].

Thierry Ponge1, Stanislas Bruley des Varannes

  • 1Hôtel-Dieu 44093 Nantes. ThierryPonge@aol.com

La Revue Du Praticien
|January 21, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First genome-wide association study reveals immune-mediated aetiopathology in idiopathic achalasia.

Gut·2025
Same author

A Non-Pharmacological Paradigm Captures the Complexity in the Mechanism of Action of Poliprotect Against Gastroesophageal Reflux Disease and Dyspepsia.

International journal of molecular sciences·2025
Same author

Probiotics plus vitamin D in irritable bowel syndrome: a prospective multicentric non-interventional study.

Minerva gastroenterology·2024
Same author

Guidelines for the management of chronic cough in adults. Endorsed by the French speaking society of respiratory diseases (Société de Pneumologie de Langue Française, SPLF), the Société Française d'Oto-Rhino-Laryngologie et de Chirurgie de la Face et du Cou (SFORL), the Société Française de Phoniatrie et de Laryngologie (SFPL), the Société Nationale Française de Gastro-entérologie (SNFGE).

Respiratory medicine and research·2023
Same author

Could the Microbiota Be a Predictive Factor for the Clinical Response to Probiotic Supplementation in IBS-D? A Cohort Study.

Microorganisms·2023
Same author

Peroral endoscopic myotomy: is it better to perform it in naive patients or as second-line therapy? Results of an open-label-controlled study in 105 patients.

Surgical endoscopy·2023
Same journal

[Prolonged fever].

La Revue du praticien·2026
Same journal

[Lower gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[Management of antiplatelet agents and oral anticoagulants in cases of gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[A history of child abuse intervention in the West].

La Revue du praticien·2026
Same journal

[Agranulocytose médicamenteuse].

La Revue du praticien·2026
Same journal

[Patient education in heart failure].

La Revue du praticien·2026
See all related articles

Systemic sclerosis frequently affects the digestive system, causing serious complications. Early diagnosis and systematic symptomatic treatments are crucial for improving patient prognosis and managing gastrointestinal issues.

Area of Science:

  • Gastroenterology
  • Rheumatology
  • Systemic Autoimmune Diseases

Context:

  • Digestive involvement is a frequent and serious complication of systemic sclerosis.
  • Pathophysiology involves neural dysfunction, smooth muscle atrophy, and fibrosis.
  • Gastrointestinal manifestations significantly contribute to morbidity and mortality.

Purpose:

  • To outline the spectrum of digestive system involvement in systemic sclerosis.
  • To highlight the pathophysiological mechanisms and clinical consequences.
  • To emphasize the importance of diagnostic tools and symptomatic treatments.

Summary:

  • Oesophageal issues include gastroesophageal reflux and erosive oesophagitis, diagnosed via manometry and endoscopy.
  • Gastric and small intestinal involvement can lead to malabsorption, pseudoobstruction, and bacterial overgrowth.

Related Experiment Videos

  • Colonic and anorectal complications include fecal incontinence and rectal prolapse; Reynold's syndrome is a specific association.

    • Impact:

    • Understanding digestive manifestations aids in early diagnosis and management.
    • Systematic symptomatic treatments are essential for improving the overall prognosis of systemic sclerosis patients.
    • This comprehensive overview supports clinical decision-making and patient care strategies.